Bone-Strengthening Drugs

Bone-strengthening drugs slow bone breakdown and may help protect bones affected by cancer or weakened by treatment.

This group includes medicines such as bisphosphonates and denosumab. They work on cells that remove old bone, helping the balance between bone breakdown and repair. The choice depends on the reason for treatment, kidney function, calcium levels, dental health, and other medicines.

Bisphosphonates attach to bone and reduce the activity of bone-removing cells. Denosumab blocks a signal needed by those cells. Both approaches can reduce the release of minerals from bone and may ease problems caused by fragile or cancer-affected bone.

These medicines do not remove a tumour. They are supportive treatment and are used alongside the cancer plan when the clinical team believes bone protection could help.

In oncology, these drugs may be used when cancer has spread to bone, when bone damage creates pain or fracture risk, or when treatment affects bone density. They may also be used for high calcium levels related to cancer. The schedule and route vary: some medicines are given by infusion, while others are given by injection.

Before treatment, the team reviews calcium, kidney function, symptoms, and any planned dental work. Report new bone pain, weakness, trouble walking, or changes in bladder or bowel control quickly, because these symptoms can require urgent assessment.

Bone protection may also involve pain relief, radiotherapy to a painful bone area, surgery or stabilisation for a threatened fracture, physiotherapy, and advice about movement and falls. Calcium or vitamin D may be recommended when appropriate, but supplements are not a substitute for an oncology assessment. The treatment team chooses the combination according to scans, symptoms, and general health.

Possible effects include muscle or joint aches, flu-like feelings after an infusion, changes in calcium, and irritation at an injection site. Kidney checks and mineral blood tests help the team decide whether treatment can continue safely. Seek prompt advice for severe weakness, confusion, muscle spasms, or a new inability to walk.

Tell your cancer team about dental pain, loose teeth, gum swelling, or planned tooth removal before a dose. Keep brushing and cleaning between teeth as advised, and do not begin supplements without checking the amount with your clinician.

Bone-strengthening treatment may continue while it is helping and remains suitable, with regular review of symptoms, scans, blood tests, and side effects. A dose can be delayed or changed when kidney function, calcium, dental health, or overall condition changes.

Rare but serious jaw complications are more likely around invasive dental procedures, so coordinate dental care with the oncology team. Report persistent thigh or groin pain, new swelling, or severe pain after treatment rather than waiting for the next appointment.